Polpharma BiologicsS.A.Active
Research and experimental development in natural sciences and engineering
KRS: 0000763945 NIP: 9571112470 REGON: 38217394800000
Overview
Registry date
2018-12-31
Share capital
$495,266,963.80
Activity description
Polpharma Biologics is a biotechnology company that specializes in the development and manufacturing of biosimilars and innovative biologics. They provide customized CDMO services, taking biosimilars from concept to clinical trials and supporting global commercial supply. The company collaborates with major biopharmaceutical partners to enhance patient access to high-quality alternatives for various diseases.
Registered address
Ul. Trzy Lipy 3, 80-172 Gdańsk, Poland
Website
polpharmabiologics.comWebsite active
Electronic delivery address
AE:PL-37878-93960-EAVTH-17
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-01-09.Active
- 53 1030 1016 0000 0000 9301 4401
- 10 1030 1016 0000 0000 9301 4496
- 80 1030 1016 0000 0000 9301 4497
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Captor TherapeuticsS.A. | $9,334,706.84 | captortherapeutics.pl | |
| MikroelS.A. | $7,850,249.12 | mikroel.tech | |
| Centrum Techniki OkrętowejS.A. | $7,668,943.94 | cto.gda.pl | |
| BiokineticaS.A. | $2,726,207.44 | biokinetica.com | |
| IntodnaS.A. | $1,629,637.22 | intodna.com | |
| ProgresjaS.A. | $1,078,849.89 | progresja.co | |
| REAL ResearchS.A. | $565,296.66 | real-research.com/ | |
| BioceltixS.A. | $492,206.18 | bioceltix.com/ | |
| PolbionicaS.A. | $225,022.81 | polbionica.com/ | |
| NanosanguisS.A. | $133,800.85 | nanosanguis.com |
Change history
| Event | Details | Date | |
|---|---|---|---|
| PKD change | Added: 52.10.B | 2026-04-17 |
FAQ
Last updated: 2026-04-17